An improved understanding of the importance of ADAM17 and the downstream EGFR signaling pathway in esophageal cancer invasion may aid in the development of therapeutic strategies aimed at reducing the invasiveness of esophageal cancer. Here, EGFR is linked to esophageal cancer.